← Back to Clinical Trials
Recruiting NCT07156890

NCT07156890 Surveillance of Respiratory Viruses in Healthcare and Animal Workers

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07156890
Status Recruiting
Phase —
Sponsor Erasmus Medical Center
Condition Respiratory Viruses
Study Type OBSERVATIONAL
Enrollment 250 participants
Start Date 2024-08-19
Primary Completion 2029-08

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type OBSERVATIONAL

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 250 participants in total. It began in 2024-08-19 with a primary completion date of 2029-08.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Outbreaks with viruses occur continuously, and novel viruses or new variants of existing viruses can surface after a zoonotic event or human-to-human transmission. This project proposal is designed to detect early circulation of (novel) respiratory viruses in both symptomatic and asymptomatic participants, either by direct detection of the virus or changes in local or systemic immunity. Additionally, SENTINEL will provide information on infectivity and (protective) immune responses in viral outbreaks or vaccination campaigns.

Eligibility Criteria

Inclusion Criteria: * 18 years or older * Health care workers with or without direct patient contact * Animal workers with or without direct animal contact Exclusion Criteria: * \<18 years

Contact & Investigator

Central Contact

Corine H. Geurts van Kessel, Dr

✉ c.geurtsvankessel@erasmusmc.nl

📞 +31643271384

Frequently Asked Questions

Who can join the NCT07156890 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Respiratory Viruses. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07156890 currently recruiting?

Yes, NCT07156890 is actively recruiting participants. Contact the research team at c.geurtsvankessel@erasmusmc.nl for enrollment information.

Where is the NCT07156890 trial being conducted?

This trial is being conducted at Rotterdam, Netherlands.

Who is sponsoring the NCT07156890 clinical trial?

NCT07156890 is sponsored by Erasmus Medical Center. The trial plans to enroll 250 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology